Research Article
[Retracted] Analysis of Clinicopathological Factors Associated with Radiation-Induced Cystitis in Patients with Cervical Cancer
Table 1
Characteristics for 107 patients with cervical cancer.
| Item | Subcategory | No. | % |
| Age | >60 | 23 | 21.5 | 40∼60 | 79 | 73.8 | <40 | 5 | 4.7 | Pathological type | Squamous cell carcinoma | 107 | 100.0 | Adenocarcinoma | 0 | 0.0 | Adenosquamous carcinoma | 0 | 0.0 | FIGO stage | I | 34 | 31.8 | II | 43 | 40.1 | III/IV | 30 | 28.0 | Treatment modality | Surgery + post-op RT | 65 | 60.7 | Concurrent chemo RT | 38 | 35.5 | RT alone | 4 | 3.7 | Chemotherapy cycle | 1∼2 | 22 | 20.6 | 3∼4 | 43 | 40.2 | 5∼6 | 28 | 26.2 | >6 | 10 | 9.3 | RT technique | 3D-CRT | 0 | 0.0 | IMRT/VMAT | 107 | 100.0 | Dose for RT dose(Gy) | >60 | 7 | 6.5 | 60 | 45 | 42.1 | 50 | 46 | 43.0 | 45/46 | 9 | 8.4 | Bladder toxicity (CTCAE grade) | 0 | 74 | 69.2 | 1 | 23 | 21.5 | 2 | 5 | 4.7 | 3 | 5 | 4.7 | 4 | 0 | 0.0 | 5 | 0 | 0.0 |
|
|
RT: radiotherapy; Post-RT: post-operative CRT; Chemo-RT: CRT; 3D-CRT: 3-dimensional conformal radiotherapy; IMRT: intensify modulated radiotherapy; VMAT: volumetric modulated arc radiotherapy; CTCAE: common terminology criteria for adverse events.
|